CHELMSFORD, Mass., July 25, 2019 /PRNewswire/ — Brooks Life Sciences expanded the FluidX Next-Gen Sample Tube range, providing flexibility through the widest range of coded sample tubes available in the industry. Comprising of 18 sample tubes – you have the flexibility of choosing a tube that fits your workflow, not changing your workflow to fit the tube.
What is a FluidX Next-Gen Sample Tube?
The FluidX Next-Gen Sample Tube range benefits from nearly 20 years of experience manufacturing and supplying coded tubes to biobanks, compound management groups, basic research labs, genomic labs and more. The Next-Generation manufacturing technique is used to integrate 2 resin colors into the same tube enabling high-resolution coding and reliable readability. With several industry-leading key benefits, FluidX Next-Gen Sample Tubes help protect sample integrity and support lab efficiency.
The key benefits are:
Evelyn Stevenson, FluidX Range Consumables Product Manager said; “We’re very proud of our expanded range of FluidX Next-Gen Sample Tubes. Not only can we offer customers the widest range available, but we also feature industry leading benefits to protect sample integrity and promote lab efficiency across a range of applications”.
Further, Brooks Life Sciences is also pleased to announce the rationalized naming structure for the FluidX Sample Tubes. This can be found in the glossary of the new Sample Tube Consumables and Instruments catalogue.
To learn more about the FluidX Next-Gen Sample Tube range and to order a new sample pack or download the new catalogue visit www.brookslifesciences.com. If you would like to speak directly to us, please contact:
Mike Thurogood – Marketing Director, Brooks Life Sciences Mike.Thurogood@brooks.com
Evelyn Stevenson – Product Manager, Brooks Life Sciences Evelyn.Stevenson@brooks.com
View original content:http://www.prnewswire.com/news-releases/expanded-fluidx-next-gen-sample-tube-range–the-most-comprehensive-range-of-sample-tubes-available-300891024.html
SOURCE Brooks Life Sciences
12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel…
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…
The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…
MARKHAM, Ontario, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:…
TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and…